Carver Bancorp, Inc. Announces Board Modernization Initiative with Comprehensive Governance Enhancements

— Governance changes are designed to align Carver's board policies with leading companies, reinforcing the board's fiduciary commitment to all shareholders. — The modernization plan includes a 75% turnover rate among directors over the next 3 years and the implementation of enhanced skills-based recruitment. — Restructured equity-based compensation preserves capital flexibility while aligning directors' interests […]

Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting

Ira Mellman, PhD, President of Research, to receive SITC's Richard V. Smalley Memorial Award for his significant contributions to the advancement of cancer immunotherapy research PICI leaders, investigators, and collaborators contributing to more than 75 posters, presentations, and panels throughout the meeting The Parker Institute for CancerImmunotherapy (PICI), today announced that research and expertise from

Petauri Announces Leadership Transition for Petauri Advance

Petauri, a leading purpose-built pharmaceutical services platform, today announced a leadership transition within its medical and scientific communications division, Petauri Advance. This move underscores the company's commitment to delivering unrivaled therapeutic area expertise, paired with the agility, client service, and innovation of independent healthcare agencies. https://mma.prnewswire.com/media/2543667/Petauri_Logo.jpg Lisa Hefner has been appointed Group President of Petauri

Engineering Peptide Stability Through Azapeptide Synthesis and Applications, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how azapeptide strategies can enhance peptide stability and accelerate synthesis workflows. Attendees will gain insight into strategies to incorporate aza-amino acids into molecules containing natural amino acids and linkages. The featured speakers will discuss applications demonstrating the utility of unique physicochemical properties of azapeptides. Attendees will learn about automating alternative

Pinpoint Clinical Trial Participants with Precision Feasibility and RWD, Upcoming Webinar Hosted by Xtalks

In this free webinar, the presenters will discuss how to reach the right patients faster with precision insights into who they are, where they are and when they're ready. Attendees will learn how to accelerate trial enablement, boost recruitment results with next-generation, outcome-based, last-mile engagement services. In today's complex clinical trial landscape, traditional site selection

Streamlining Cell Line Development for Faster Biologics Production, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how streamlined cell line development supports faster, more reliable biologics production and a smoother transition to clinical manufacturing. We will begin discussing the benefits of transposase-mediated integration technology.The featured speakers will share key considerations for regulatory readiness and product stability. Attendees will learn about cell line and upstream process development

Enhancing Cardiometabolic Trials with Configurable eCOA and Digital Health Technologies, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how to enhance cardiometabolic trials using configurable eCOA and digital health technologies. The featured speakers will discuss how Clinical ink's configurable eCOA platform accelerates study builds and enables robust trial design. Attendees will gain insight into supported DHT devices, including CGMs, BGMs, smart scales and wearable monitors used in a

Veris Residential Declares Fourth Quarter 2025 Cash Dividend

Veris Residential, Inc. (NYSE: VRE) (“Veris Residential” or the “Company”), a forward-thinking, Northeast-focused, Class A multifamily REIT, today announced that the Company's Board of Directors has declared a cash dividend on its common stock for the fourth quarter 2025 in the amount of $0.08 for the period ending December 31, 2025. The dividend will be

SWIRL Joins iManage Technology Partner Program, Expanding Customer Choice for Secure, AI-Powered Knowledge Discovery

SWIRL, the leader in secure, federated AI search, today announced it has joined the iManage Technology Partner Program. The integration between SWIRL and iManage, the company dedicated to Making Knowledge Work™, provides customers an additional option to unify discovery. Organizations in legal, financial services, and other knowledge-intensive sectors face a persistent challenge: critical information is

Walbridge Earns Supplier of the Year Award from Stellantis for Operational Excellence

Walbridge, a leading full-service construction company, was recognized by Stellantis as the 2025 North American Supplier of the Year at the company's fifth annual Supplier of the Year ceremony and convention in Paris, France, on October 28, 2025. https://mma.prnewswire.com/media/2468642/WalbridgeLOGO_Black_RGB_NO_BACKGROUND_Logo.jpg As one of only 20 suppliers to receive this distinction for remarkable performance, reliability, and commitment

Scroll to Top